search
for
 About Bioline  All Journals  Testimonials  Membership  News


Middle East Fertility Society Journal
Middle East Fertility Society
ISSN: 1110-5690
Vol. 12, No. 1, 2007, pp. 53-56
Bioline Code: mf07009
Full paper language: English
Document type: Research Article
Document available free of charge

Middle East Fertility Society Journal, Vol. 12, No. 1, 2007, pp. 53-56

 en Oral versus rectal route of misoprostol administration: a randomized controlled trial
Hassan, Farid Ibrahim; Mostapha, Mohamed Khalid; Sattar, Mahmoud Abdel; Marouf, Emad & Azim, Shokry Abdel

Abstract

Objective: to compare between the efficacy of oral versus rectal misoprostol in the treatment of incomplete abortion.
Design: prospective controlled trial. Patients were allocated to intervention using alternate sequence
Setting: Al-Hussein Hospital, Al-Azhar University
Materials and methods: one hundred women with retained products of conception were divided into two groups: G1: fifty women received misoprostol 200 μg misoprostol/4 hs rectally and G2; fifty women received it orally. Follow up and side effects were recorded
Results: There was no significant difference between both groups regarding their background characteristics, response to misoprostol, need to do D&C or side effects. the dose of 200ug misoprostol every 4 hours (orally and rectally) for a maximum of 3 doses was not only effective in complete evacuation but also had low incidence of side-effects especially vomiting diarrhea and bleeding
Conclusion: misoprostol whether by oral or rectal route seems to be an effective as a non invasive method for evacuation of the uterus in women with retained products of conception.

Keywords
Misoprostol, incomplete abortion

 
© Copyright 2007 - Middle East Fertility Society
Alternative site location: http://www.mefsjournal.org

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil